Remove Clinical Trials Remove Collective Remove Epilepsy
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

It reviews about half a dozen such studies, plus another ten looking at transdermal CBD for other conditions, including drug addiction, neurodegeneration, skin cancer, wound healing, and epilepsy. New clinical trials are urgently needed, they repeat in a familiar refrain. A killer app for pain?

Topical 178
article thumbnail

Cannabinoids for Tinnitus?

Project CBD

5 As far as human studies, the review authors also summarize two previous surveys in 2010 and 2019, a 1975 clinical trial and a 2006 case study — whose cumulative findings are, at best, entirely unclear. While the collective evidence to date is mixed and inconclusive, it’s also incomplete.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Not-very-NICE: UK Cannabis Policy and Harm to Patients

CannaTech

Last week NICE released the first draft of their evidence-based guidelines, concluding it could not recommend CBMPs for routine use because of high cost and a dearth of clinical trial evidence. Furthermore, pharmaceutical companies often fund and initiate randomised clinical trials to validate their drugs.

article thumbnail

‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners

Cannabis Law Report

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. This would answer questions about safety and efficacy, they said.

article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

article thumbnail

NHS To Launch Its First Evidence-Based Cannabis Patient Data Registry This Week – Cannabis Business Executive

SpeedWeed

At this stage we need a middle ground and establishing a registry to collect data is a sensible way forward and will be very useful. “It It is going to allow us to collect data that can be shared on how cannabis medicines are prescribed and the benefits patients get. Boost For NHS Cannabis Prescribing .

Data 52
article thumbnail

How Cannabis Research is Affecting Parkinson’s Disease

The Joint Blog

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s?